These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10477143)

  • 1. The angiotensin-converting enzyme genotype and microalbuminuria in autosomal dominant polycystic kidney disease.
    van Dijk MA; Peters DJ; Breuning MH; Chang PC
    J Am Soc Nephrol; 1999 Sep; 10(9):1916-20. PubMed ID: 10477143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis.
    Pereira TV; Nunes AC; Rudnicki M; Magistroni R; Albertazzi A; Pereira AC; Krieger JE
    Nephrol Dial Transplant; 2006 Nov; 21(11):3155-63. PubMed ID: 16935894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease.
    Pérez-Oller L; Torra R; Badenas C; Milà M; Darnell A
    Am J Kidney Dis; 1999 Aug; 34(2):273-8. PubMed ID: 10430974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease.
    Lee KB; Kim UK; Lee CC
    J Korean Med Sci; 2000 Aug; 15(4):431-5. PubMed ID: 10983692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of angiotensin converting enzyme (
    Ramanathan G; Ghosh S; Elumalai R; Periyasamy S; Lakkakula BV
    Indian J Med Res; 2016 Jun; 143(6):748-755. PubMed ID: 27748299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ACE insertion/deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease.
    van Dijk MA; Breuning MH; Peters DJ; Chang PC
    Nephrol Dial Transplant; 2000 Jun; 15(6):836-9. PubMed ID: 10831637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease.
    Schiavello T; Burke V; Bogdanova N; Jasik P; Melsom S; Boudville N; Robertson K; Angelicheva D; Dworniczak B; Lemmens M; Horst J; Todorov V; Dimitrakov D; Sulowicz W; Krasniak A; Stompor T; Beilin L; Hallmayer J; Kalaydjieva L; Thomas M
    Nephrol Dial Transplant; 2001 Dec; 16(12):2323-7. PubMed ID: 11733623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension.
    Zivko M; Kusec R; Galesić K
    Coll Antropol; 2013 Sep; 37(3):765-70. PubMed ID: 24308214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease.
    Baboolal K; Ravine D; Daniels J; Williams N; Holmans P; Coles GA; Williams JD
    Kidney Int; 1997 Sep; 52(3):607-13. PubMed ID: 9291178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No effect of angiotensin-converting enzyme gene polymorphism on disease progression and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
    Ecder T; McFann KK; Raynolds MV; Schrier RW
    Am J Nephrol; 2003; 23(6):466-70. PubMed ID: 14600431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between angiotensin converting enzyme gene polymorphism and clinical features in autosomal dominant polycystic kidney disease.
    Uemasu J; Nakaoka A; Kawasaki H; Ishikawa I; Yoshino Y; Shio H; Nemoto R; Nakamura I; Morio S
    Life Sci; 1997; 60(23):2139-44. PubMed ID: 9180368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension.
    Pontremoli R; Sofia A; Tirotta A; Ravera M; Nicolella C; Viazzi F; Bezante GP; Borgia L; Bobola N; Ravazzolo R; Sacchi G; Deferrari G
    J Am Soc Nephrol; 1996 Dec; 7(12):2550-8. PubMed ID: 8989733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.
    van der Kleij FG; Schmidt A; Navis GJ; Haas M; Yilmaz N; de Jong PE; Mayer G; de Zeeuw D
    Kidney Int Suppl; 1997 Dec; 63():S23-6. PubMed ID: 9407415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microalbuminuria in normotensive patients with autosomal-dominant polycystic kidney disease.
    Martinez-Vea A; Gutierrez C; Bardají A; Pastor R; García C; Peralta C; Richart C; Oliver JA
    Scand J Urol Nephrol; 1998 Sep; 32(5):356-9. PubMed ID: 9825400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease.
    Persu A; El-Khattabi O; Messiaen T; Pirson Y; Chauveau D; Devuyst O
    Nephrol Dial Transplant; 2003 Oct; 18(10):2032-8. PubMed ID: 13679477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years.
    Huang XH; Rantalaiho V; Wirta O; Pasternack A; Hiltunen TP; Koivula T; Malminiemi K; Nikkari T; Lehtimäki T
    Nephron; 1998 Sep; 80(1):17-24. PubMed ID: 9730698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the alpha-adducin and ACE gene polymorphism on the progression of autosomal-dominant polycystic kidney disease.
    Merta M; Reiterová J; Stekrová J; Rysava R; Rihová Z; Tesar V; Viklický O; Kmentova D
    Kidney Blood Press Res; 2003; 26(1):42-9. PubMed ID: 12697976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria.
    Moriyama T; Kitamura H; Ochi S; Izumi M; Yokoyama K; Yamauchi A; Ueda N; Kamada T; Imai E
    J Am Soc Nephrol; 1995 Dec; 6(6):1676-8. PubMed ID: 8749698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis.
    Yoshioka T; Xu YX; Yoshida H; Shiraga H; Muraki T; Ito K
    Arch Dis Child; 1998 Nov; 79(5):394-9. PubMed ID: 10193250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.